From clinic to classroom: How two physicians are rethinking healthcare through business
The Wharton MBA and Lauder Institute MA in International Studies joint-degree program emphasizes regional expertise, culture, and policy so its students can learn to develop healthcare solutions.
2 min. read
What drives a practicing physician to step away from medicine and pursue an MBA? For Samuel Nathan, a doctor from Ghana, and Dan Menéndez, a U.K.-trained physician, the answer lies in a shared realization: Improving healthcare often requires more than clinical expertise. Nathan and Menéndez are both students in the Wharton MBA and Lauder Institute MA in International Studies joint-degree program.
Samuel Nathan (left) and Dan Menéndez, students in the Wharton MBA and Lauder Institute MA in International Studies joint-degree program
(Image: Courtesy of The Lauder Institute)
The turning point for Samuel Nathan was the reality that a routine yet lifesaving CT scan was unaffordable. “You cannot treat them, not because you don’t have the skill but because the system is flawed,” he recalls. Insurance gaps, pricing barriers, and infrastructure constraints dictated outcomes long before a doctor could intervene. “A lot of medical doctors in Ghana feel very helpless,” he says. Nathan began to realize he could be more effective not as a clinician treating individual cases, but as a problem-solver confronting structural failure.
At Lauder, Nathan says, “I’ve realized there are so many stakeholders shaping outcomes—five, six, seven different layers beyond patients, but culture is key.” He points to informal savings systems across African communities, where groups pool money and distribute it to those most in need of treatment, as a blueprint for designing health insurance adoption. “If you want to introduce a health insurance model, you need to approach it from a cultural perspective.” Such solutions are inseparable, he says, from the broader economic opportunities in Africa. He is exploring these ideas at Lauder through the Politics and Policy Program, researching how African countries can align regulations to strengthen local pharmaceutical manufacturing.
As a resident doctor inside England’s National Health Service, Dan Menéndez encountered a quieter but persistent friction between those delivering care and those managing it. “A lot of the time, it felt that the managers didn’t quite understand the lived experiences of doctors,” he says.
Trained in medicine at King’s College London, Menéndez was taught to think across human, veterinary, and environmental health, from public health systems to infectious disease dynamics. In theory, it was an integrated view of how health actually works. In practice, he found fragmentation and systems operating in parallel rather than in sync.
“I wanted to understand all the sides of the system,” he explains. An MBA in management and finance, paired with Lauder’s cultural and international MA, offered that bridge. Having lived across multiple countries, Menéndez says, “I’m a big believer that people need to understand each other’s cultures to find real solutions.”
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
